Journal article
Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial Fibrillation
Thoracic cancer, Vol.16(1), p.e15518
01/2025
DOI: 10.1111/1759-7714.15518
PMCID: PMC11726696
PMID: 39788889
Appears in UI Libraries Support Open Access
Abstract
This illustrates the outcomes of patients with esophageal cancer undergoing neoadjuvant concurrent chemoradiation and esophagectomy, specifically focusing on those who develop new-onset atrial fibrillation (NOAF). Statistically significant findings (p < 0.05, dark red) increased mortality and ventricular fibrillation, as well as trends of (p > 0.05, light red) myocardial infarction and pericardial effusion among NOAF patients. The data emphasize the significant cardiovascular risks associated with NOAF in this population.
Details
- Title: Subtitle
- Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial Fibrillation
- Creators
- Stefano H Byer - University of IowaAravinthasamy Sivamurugan - University of Iowa, AnesthesiaUdhayvir S Grewal - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- Thoracic cancer, Vol.16(1), p.e15518
- DOI
- 10.1111/1759-7714.15518
- PMID
- 39788889
- PMCID
- PMC11726696
- NLM abbreviation
- Thorac Cancer
- ISSN
- 1759-7714
- eISSN
- 1759-7714
- Publisher
- Wiley
- Language
- English
- Date published
- 01/2025
- Academic Unit
- Anesthesia
- Record Identifier
- 9984772372602771
Metrics
4 Record Views